Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03998319 |
| Consolidated Lead Sponsor | University of Sydney |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 445 participants (ESTIMATED) |
| Registered Start Date | 2021-10-14 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Royal Prince Alfred Hospital | Camperdown, Australia | Open Hospital Dossier -> |
| Concord Repatriation General Hospital | Concord, Australia | Open Hospital Dossier -> |
| Liverpool Hospital | Liverpool, Australia | Open Hospital Dossier -> |
| Royal Adelaide Hospital | Adelaide, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.